Terms: = Brain cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Treatment
5 results:
1. Radiographic and Hormonal Regression in Prolactinomas: An Analysis of treatment Failure.
Akinduro OO; Lu VM; Izzo A; De Biase G; Vilanilam G; Van Gompel JJ; Bernet V; Donaldson A; Olomu O; Meyer FB; Quinones-Hinojosa A; Chaichana KL
World Neurosurg; 2019 Sep; 129():e686-e694. PubMed ID: 31181361
[TBL] [Abstract] [Full Text] [Related]
2. dek proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
Feng T; Liu Y; Li C; Li Z; Cai H
Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
[TBL] [Abstract] [Full Text] [Related]
3. treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas.
Schwetz V; Librizzi R; Trummer C; Theiler G; Stiegler C; Pieber TR; Obermayer-Pietsch B; Pilz S
Metab Brain Dis; 2017 Feb; 32(1):155-161. PubMed ID: 27525431
[TBL] [Abstract] [Full Text] [Related]
4. Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.
Klubo-Gwiezdzinska J; Burman KD; Van Nostrand D; Mete M; Jonklaas J; Wartofsky L
Thyroid; 2012 Mar; 22(3):310-7. PubMed ID: 22313411
[TBL] [Abstract] [Full Text] [Related]
5. The identification of novel therapeutic targets for the treatment of malignant brain tumors.
Kroes RA; Jastrow A; McLone MG; Yamamoto H; Colley P; Kersey DS; Yong VW; Mkrdichian E; Cerullo L; Leestma J; Moskal JR
Cancer Lett; 2000 Aug; 156(2):191-8. PubMed ID: 10880769
[TBL] [Abstract] [Full Text] [Related]
